Major Pharmaceutical Companies Raise Sales Forecasts Amid Strong Drug Demand

Key Intelligence

• ■Pfizer, Merck, Novo Nordisk, and Gilead have all raised their sales guidance or beaten expectations, signaling robust performance across the pharmaceutical sector.
• ■Demand for both established drugs, such as Pfizer's older portfolio and Gilead's HIV prevention treatments, and newer innovations, like Merck's latest offerings, is driving growth.
• ■The surging popularity of GLP-1 drugs for obesity and related conditions is a significant growth driver, particularly for companies like Eli Lilly and Novo Nordisk.
• ■Eli Lilly's stock has seen a major rally fueled by its obesity drugs, leading to speculation about a potential stock split.
• ■The strong financial performance reflects continued high demand for pharmaceutical products globally across various therapeutic areas.